Member Info for Riesgo

AI shows “fari” Persian word meaning glory or splendor, a not-for-profit.

They emailed me another link, but same thing. Stuck in a loop trying to confirm I’m human. I can’t wait as my fuel is running low.

Me too.

Just said on TV that the King is receiving weekly treatment. My wife was treated on a 3 weekly cycle and I’ve only ever seen reference to 2 weekly cycles with Avacta. Is anyone doing a weekly cycle?

Think he also hid away after the ‘wrong antibody’ LFT was announced.

Previously, for similar presentations, we’ve been told that no new material information will be released. As this same statement isn’t in the recent RNS there is a high probability material information will be released before the presentation on Wednesday.

Then financial results for last year on the 25th. Investor presentation the same day at 11am. Fireworks expected if there is some indication of exceeding market expectation.

That’s a bit rich. You’ve been calling it FUD for years.

If this is the current offering then it should not take long to become the new standard.
https://amp.cancer.org/treatment/treatments-and-side-effects/treatment-types/tumor-agnostic-drugs.html

Paras from here.
https://www.cancer.net/blog/2018-12/tumor-agnostic-treatment-cancer-expert-perspective

Came across this a few hours ago that discusses agnostic. Two paras are very interesting. Suggesting to me that things could soon progress very quickly.

Doctors and scientists are always looking for better ways to care for people with cancer. To make scientific advances, doctors create research studies involving volunteers, called clinical trials. Every FDA-approved drug was tested in clinical trials. In most clinical trials, the volunteers are people with the same type of cancer. However, tumor-agnostic treatments are often studied in a special type of clinical trial called a “basket trial.

Many of these genetic changes are rare, and basket trials offer a more efficient way to study a drug in tumors with rare genetic changes. In traditional clinical trials, which usually test the effects of a drug in a single type of cancer, it is often very hard to find enough people with cancer with a rare genetic mutation who can volunteer for a study. Basket trials can be particularly useful in the study of rare cancers or cancer with rare mutations.

25/04/23

To DE 5 & beyond.

“The Safety Data Monitoring Committee (SDMC) has recommended continuation to higher dose cohorts with the aim of identifying a maximum tolerated dose (MTD) necessary to inform the dosing levels for the phase 1b and future studies. The Company expects that it will complete these additional cohorts during the first half of 2023.”

Wouldn’t make any difference. Avacta is immune to shareholders.

Already started. Though the Jan RNS could have been more explicit. It said, Safety Data Monitoring Committee (SDMC) has recommended continuation to higher dose cohorts with the aim of identifying a maximum tolerated dose (MTD) necessary to inform the dosing levels for the phase 1b and future studies. The Company expects that it will complete these additional cohorts during the first half of 2023.’
Note it says ‘complete’ and not start and complete. So already underway.

C5 has started. But the vagueness has caused fear, uncertainty and doubt. Should have mentioned ‘already started’ and not just ‘complete’.
Note that there is more than C5. ‘Cohorts’ is plural.

17/01/23 RNS - The Company expects that it will complete these additional cohorts during the first half of 2023.

Think you have misunderstood Russel. Tax still applies to pension payments.

Also, improved quicker development of new drugs without EU interference.

Has the look of someone having a large order to fill by the end of today. But I could be wrong.

“higher dose cohorts” = plural.
“expects that it will complete” = already started
“during the first half of 2023” = could be tomorrow